|Mr. Mark J. Toland||CEO, Pres & Director||703.94k||N/A||1970|
|Mr. David W. Long||CFO, Sr. VP, Sec. & Treasurer||495.51k||N/A||1970|
|Mr. Douglas Teany||Chief Operating Officer||689.13k||N/A||1972|
|Ms. Nora Dutta||Sr. VP of HR||N/A||N/A||N/A|
|Dr. J. Aaron Grantham||Chief Medical Officer of Cardiovascular||N/A||N/A||N/A|
Corindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures. Its CorPath system allows the physician to perform procedures with a control console located within an interventional cockpit; and CorPath GRX system enables the precise robotic-assisted control of guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit. The company sells its products through direct sales force, as well as through distributor and partnership relationships. It serves vascular, coronary, peripheral vascular, neurointerventional, and structural heart markets. Corindus Vascular Robotics, Inc. is headquartered in Waltham, Massachusetts.
Corindus Vascular Robotics, Inc.’s ISS Governance QualityScore as of October 4, 2019 is 7. The pillar scores are Audit: 3; Board: 5; Shareholder Rights: 8; Compensation: 9.